Literature DB >> 17684287

Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Gary W Hunninghake1, Marvin I Schwarz.   

Abstract

The cause of idiopathic pulmonary fibrosis (IPF) remains unknown. Although the observed biologic and biochemical processes associated with the disease are consistent with a fibrotic process, they are not necessarily unique to IPF. Furthermore, the importance of these observations will not be apparent until a directed therapy alters the natural history of the disease. There are essentially no studies that explain the unique histologic features of this disease. As mechanistic data accumulates, it is our opinion that these data should pass the test of explaining the clinical histologic features of the disease before it can be assumed that these features are unique for IPF.

Entities:  

Mesh:

Year:  2007        PMID: 17684287      PMCID: PMC2647596          DOI: 10.1513/pats.200702-036MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  50 in total

1.  Interstitial lung disease: are we missing formes frustes of connective tissue disease?

Authors:  V Cottin
Journal:  Eur Respir J       Date:  2006-11       Impact factor: 16.671

Review 2.  Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.

Authors:  Dean Sheppard
Journal:  Proc Am Thorac Soc       Date:  2006-07

3.  Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum.

Authors:  Carlyne D Cool; Steve D Groshong; Pradeep R Rai; Peter M Henson; J Scott Stewart; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

4.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  Christopher J Lettieri; Steven D Nathan; Scott D Barnett; Shahzad Ahmad; Andrew F Shorr
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

5.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.

Authors:  K B Baumgartner; J M Samet; C A Stidley; T V Colby; J A Waldron
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

Review 6.  Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.

Authors:  Moisés Selman; Annie Pardo
Journal:  Proc Am Thorac Soc       Date:  2006-06

7.  Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.

Authors:  W A Wallace; S E Howie
Journal:  J Pathol       Date:  1999-03       Impact factor: 7.996

8.  Gene expression profiling of familial and sporadic interstitial pneumonia.

Authors:  Ivana V Yang; Lauranell H Burch; Mark P Steele; Jordan D Savov; John W Hollingsworth; Erin McElvania-Tekippe; Katherine G Berman; Marcy C Speer; Thomas A Sporn; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2006-09-22       Impact factor: 21.405

9.  Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Sylvain Marchand-Adam; Aurélie Fabre; Arnaud André Mailleux; Joelle Marchal; Christophe Quesnel; Hiroaki Kataoka; Michel Aubier; Monique Dehoux; Paul Soler; Bruno Crestani
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

Review 10.  Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2006
View more
  10 in total

Review 1.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 2.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

3.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Authors:  Marco Checa; Víctor Ruiz; Martha Montaño; Rafael Velázquez-Cruz; Moisés Selman; Annie Pardo
Journal:  Hum Genet       Date:  2008-10-14       Impact factor: 4.132

Review 4.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

5.  Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1.

Authors:  Robert Eferl; Peter Hasselblatt; Martina Rath; Helmut Popper; Rainer Zenz; Vukoslav Komnenovic; Maria-Helena Idarraga; Lukas Kenner; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205

6.  Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.

Authors:  Rasoul Aliannejad; Mostafa Ghanei
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

7.  Sphingolipid regulation of tissue fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Open Rheumatol J       Date:  2012-06-15

8.  Intratracheal instillation of high dose adenoviral vectors is sufficient to induce lung injury and fibrosis in mice.

Authors:  Qiyuan Zhou; Tianji Chen; Melike Bozkanat; Joyce Christina F Ibe; John W Christman; J Usha Raj; Guofei Zhou
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

9.  MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.

Authors:  Stefen A Boehme; Karin Franz-Bacon; Danielle N DiTirro; Tai Wei Ly; Kevin B Bacon
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

Review 10.  Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa.

Authors:  A E Leitch; R Duffin; C Haslett; A G Rossi
Journal:  Mucosal Immunol       Date:  2008-07-02       Impact factor: 7.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.